Browsing by Author "Madhupriya, V"
Now showing 1 - 3 of 3
Results Per Page
Sort Options
ArticleItem Open Access Carcass Characteristics and Physico-chemical Properties of Broiler Meat as Influenced by Triphala in Commercial Broiler Chicken(2020-12) Madhupriya, V; Shamsudeen, P; Raj Manohar, G; Senthilkumar, S; TANUVASThe biological experiment was carried out to determine the carcass characteristics and physico-chemical properties of broiler chicken meat as influenced by Triphala supplementation in broilers. The study was carried out with three hundred commercial sexed, one day-old, broiler chicks that were randomly grouped into six treatments with five replicates for each treatment containing ten chicks per replicate. The chicks were reared from day-old to thirty five days of age in deep litter system under standard management conditions throughout the experimental period. The treatment groups were fed with basal diet without supplementation of antibiotic growth promoter/Triphala (T1) or with supplementation of oxytetracycline at 0.004 per cent (T2), or with supplementation of Triphala at 0.025 per cent (T3), 0.05 per cent (T4), 0.075 per cent (T5) or 0.10 per cent (T6). At the end of the experiment (35th day), one male and one female bird per replicate, totally ten birds per treatment group were randomly selected. Blood samples were collected for immunological and serum lipid profile study. The experiment revealed that there were no significant difference in carcass characteristics viz. eviscerated yield, yield of gizzard, heart and abdominal fat, except liver weight, in which it was found to be significantly (P<0.01) highest in group supplemented with Triphala at 0.10 per cent (T6) and lowest in control (T1). There existed no significant differences among treatment groups in physicochemical properties of breast meat of broiler chicken due to supplementation of graded levels of Triphala for a period of five weeks.ArticleItem Open Access Dietary Supplementation of Triphala on Production Performance of Commercial Broiler Chicken(2020-11) Madhupriya, V; Shamsudeen, P; Raj Manohar, G; Senthilkumar, S; TANUVASThe biological experiment was carried out with Three hundred commercial sexed, one day-old, broiler chicks that were randomly grouped into six treatments with five replicates for each treatment and containing ten chicks per replicate. The chicks were reared from day-old to thirty five days of age in deep litter system in a gable roofed, open sided poultry house. All the chicks were reared under standard management conditions throughout the experimental period. The treatment groups were fed with basal diet without supplementation of antibiotic growth promoter/Triphala (T1) or with supplementation of oxytetracycline at 0.004 per cent (T2), or with supplementation of Triphala at 0.025 per cent (T3), 0.05 per cent (T4), 0.075 per cent (T5) or 0.10 per cent (T6). The experiment revealed that the group supplemented with antibiotic growth promoter (T2) had significantly (P<0.01) higher body weight (1934.12g) and weight gain (1885.26g) than control (T1), which recorded lowest body weight (1825.12g) and weight gain (1777.92g). The groups supplemented with Triphala at 0.025 per cent (T3), 0.05 per cent (T4), 0.075 per cent (T5) and 0.10 per cent (T6) did not differ significantly with T2, whereas, the group supplemented with Triphala at 0.10 per cent (T6) had the highest body weight (1889.98g) and body weight gain (1842.42g) among the Triphala supplemented groups. The groups T5 and T6 had significantly (P<0.05) lowest feed intake (3013.86g and 3018.00g, respectively) among the treatment groups, the control group (T1), T3 and T4 were intermediary in observations, whereas, significantly highest feed intake was observed in the T2 group (3086.00g). The feed conversion ratio of broilers was significantly (P<0.05) better (1.64) in T2 and T6 followed by T5, T3 and T4, whereas the control (T1) recorded poor feed conversion ratio (1.73). There was no difference in livability among treatment groups. Hence, it is concluded that Triphala could be supplemented at 0.10 per cent in broiler diet, as an alternate to antibiotic growth promoter for improving production performance of broiler chicken.ArticleItem Open Access Serum Lipid Profile and Meat Cholesterol Levels as Influenced by Triphala in Commercial Broiler Chicken(2020-12) Madhupriya, V; Shamsudeen, P; Raj Manohar, G; Senthilkumar, S; TANUVASThe biological experiment was carried out to determine the serum lipid profile and chicken meat cholesterol levels as influenced by Triphala supplementation in broilers. A total of three hundred commercial one day-old sex separated broiler chicks were randomly grouped into six treatments with five replicates for each treatment containing ten chicks per replicate. The chicks were reared from day-old to 35 days of age in deep litter system under standard management conditions throughout the experimental period. The treatment groups were fed with basal diet without supplementation of antibiotic growth promoter / Triphala (T1) or with supplementation of Oxytetracycline at 0.004 per cent (T2), or with supplementation of Triphala at 0.025 per cent (T3), 0.05 per cent (T4), 0.075 per cent (T5) or 0.10 per cent (T6). At the end of the experiment (35th day), one male and one female bird per replicate, totally ten birds per treatment group were randomly selected. Blood samples were collected for serum lipid profile and meat cholesterol level studies. The experiment revealed that there existed no significant differences in triglycerides and very low density lipoprotein level of serum among the treatment groups. Supplementation of Triphala decreased the serum total cholesterol of broiler chicken in dose dependant fashion with lowest cholesterol recorded in the group supplemented with 0.10 per cent Triphala in diet (T6). The groups supplemented with Triphala had significantly (P<0.01) lowered total cholesterol in serum, breast and thigh meat, and increased ratio of HDL: LDL in serum of broiler chicken in a dose dependent manner with maximum effect at 0.10 per cent Triphala supplementation (T6) than control (T1) and antibiotic supplemented group (T2).